Option Care Health, Inc. $OPCH Shares Acquired by AXQ Capital LP

AXQ Capital LP boosted its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 256.2% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 40,092 shares of the company’s stock after acquiring an additional 28,836 shares during the period. AXQ Capital LP’s holdings in Option Care Health were worth $1,113,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Cornerstone Planning Group LLC grew its stake in shares of Option Care Health by 7,621.4% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock valued at $30,000 after purchasing an additional 1,067 shares during the last quarter. McIlrath & Eck LLC purchased a new stake in shares of Option Care Health during the second quarter worth approximately $37,000. Elevation Point Wealth Partners LLC purchased a new stake in shares of Option Care Health during the second quarter worth approximately $40,000. EverSource Wealth Advisors LLC lifted its holdings in shares of Option Care Health by 528.1% during the second quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock worth $46,000 after purchasing an additional 1,183 shares during the period. Finally, Hantz Financial Services Inc. grew its position in Option Care Health by 987.7% in the 3rd quarter. Hantz Financial Services Inc. now owns 1,414 shares of the company’s stock valued at $39,000 after buying an additional 1,284 shares during the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on OPCH. Weiss Ratings reiterated a “hold (c)” rating on shares of Option Care Health in a research note on Monday, December 29th. Morgan Stanley lifted their price objective on Option Care Health from $35.00 to $38.00 and gave the company an “overweight” rating in a report on Tuesday, January 13th. Wall Street Zen upgraded Option Care Health from a “hold” rating to a “buy” rating in a research report on Saturday, January 10th. Stephens raised Option Care Health to a “strong-buy” rating in a report on Thursday, December 11th. Finally, Jefferies Financial Group restated a “buy” rating and issued a $37.00 price target on shares of Option Care Health in a research note on Tuesday, January 13th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $37.58.

Option Care Health Stock Up 1.1%

OPCH opened at $36.09 on Tuesday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.05 and a current ratio of 1.56. The company has a market cap of $5.73 billion, a price-to-earnings ratio of 28.64, a PEG ratio of 2.13 and a beta of 0.84. Option Care Health, Inc. has a one year low of $24.24 and a one year high of $36.80. The business’s fifty day moving average is $33.97 and its two-hundred day moving average is $30.47.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.